Your browser doesn't support javascript.
loading
Carboplatin and pemetrexed with or without pembrolizumab for advanced, non-squamous non-small-cell lung cancer: a randomised, phase 2 cohort of the open-label KEYNOTE-021 study.
Langer, Corey J; Gadgeel, Shirish M; Borghaei, Hossein; Papadimitrakopoulou, Vassiliki A; Patnaik, Amita; Powell, Steven F; Gentzler, Ryan D; Martins, Renato G; Stevenson, James P; Jalal, Shadia I; Panwalkar, Amit; Yang, James Chih-Hsin; Gubens, Matthew; Sequist, Lecia V; Awad, Mark M; Fiore, Joseph; Ge, Yang; Raftopoulos, Harry; Gandhi, Leena.
Afiliação
  • Langer CJ; Abramson Cancer Center of the University of Pennsylvania, Philadelphia, PA, USA. Electronic address: corey.langer@uphs.upenn.edu.
  • Gadgeel SM; Karmanos Cancer Institute and Wayne State University, Detroit, MI, USA.
  • Borghaei H; Fox Chase Cancer Center, Philadelphia, PA, USA.
  • Papadimitrakopoulou VA; The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
  • Patnaik A; South Texas Accelerated Research Therapeutics, San Antonio, TX, USA.
  • Powell SF; Sanford Cancer Center, Sioux Falls, SD, USA.
  • Gentzler RD; University of Virginia, Charlottesville, VA, USA.
  • Martins RG; University of Washington and Seattle Cancer Care Alliance, Seattle, WA, USA.
  • Stevenson JP; Cleveland Clinic, Cleveland, OH, USA.
  • Jalal SI; Indiana University School of Medicine, Indianapolis, IN, USA.
  • Panwalkar A; Sanford Roger Maris Cancer Center, Fargo, ND, USA.
  • Yang JC; National Taiwan University Hospital and National Taiwan University Cancer Center, Taipei, Taiwan.
  • Gubens M; University of California, San Francisco, San Francisco, CA, USA.
  • Sequist LV; Massachusetts General Hospital Cancer Center and Harvard Medical School, Boston, MA, USA.
  • Awad MM; Dana-Farber Cancer Institute, Boston, MA, USA.
  • Fiore J; Merck & Co Inc, Kenilworth, NJ, USA.
  • Ge Y; Merck & Co Inc, Kenilworth, NJ, USA.
  • Raftopoulos H; Merck & Co Inc, Kenilworth, NJ, USA.
  • Gandhi L; Dana-Farber Cancer Institute, Boston, MA, USA; Laura and Isaac Perlmutter Cancer Center, NYU Langone Medical Center, New York, NY, USA.
Lancet Oncol ; 17(11): 1497-1508, 2016 Nov.
Article em En | MEDLINE | ID: mdl-27745820
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Protocolos de Quimioterapia Combinada Antineoplásica / Carcinoma Pulmonar de Células não Pequenas / Neoplasias Pulmonares Tipo de estudo: Clinical_trials / Etiology_studies / Risk_factors_studies Limite: Aged / Female / Humans / Male / Middle aged Idioma: En Revista: Lancet Oncol Assunto da revista: NEOPLASIAS Ano de publicação: 2016 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Protocolos de Quimioterapia Combinada Antineoplásica / Carcinoma Pulmonar de Células não Pequenas / Neoplasias Pulmonares Tipo de estudo: Clinical_trials / Etiology_studies / Risk_factors_studies Limite: Aged / Female / Humans / Male / Middle aged Idioma: En Revista: Lancet Oncol Assunto da revista: NEOPLASIAS Ano de publicação: 2016 Tipo de documento: Article